Simponi SmartJect autoinjectors Recalled

Washington, DC: Centocor Ortho Biotec, the maker of the tumor necrosis factor alpha inhibitor Simponi (golimumab ) used to treat rheumatoid arthritis, has recalled a single lot of Simponi 50 mg single dose SmartJect autoinjectors because the device may fail to deliver the full 0.5 mL therapy. The recall was prompted by a manufacturing error.

The recall affects lot number 09D071.AC.

The recall reportedly does not affect Simponi 50 mg prefilled syringes.

Legal Help

If you or a loved one has suffered an adverse health event resulting from the use of this product, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Published on Feb-22-11